Connexin biology is a rapidly evolving field that plays a crucial role in intercellular communication through gap junctions ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

More than 7,000 Hampshire people have helped Southampton scientists with a ground-breaking study to find new ways to diagnose ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

New research from Drexel University’s A.J. Drexel Autism Institute found that the use of standardized autism screening during ...

In 2017, the CONSORT-CHM Formulas 2017 extension was introduced to enhance the reporting transparency of randomized ...

The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

Hospitals are already deploying artificial intelligence (AI) to enhance patient care. But can it actually improve doctors' diagnoses? A new study has surprising answers.